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Abstracts / International Journal of Surgery 8 (2010) 501–578 571tumours is less well reported.We report our initial experience of managing
multiple small renal tumours with cryotherapy in high risk patients with
considerable co-morbidities.
Materials and methods: In 18 months, we treated 2 patients with
multiple small renal tumours with laparoscopic cryoablation. They both
had signiﬁcant comorbidities (ASA3), but maintained an active quality of
life. A transperitoneal approachwas used in both. Four and three ipsilateral
renal tumours ranging from 10mm to 30mm were treated with 5 and 4
cryotherapy needles (2.4mm) respectively. The treatment included double
10 minute freeze-thaw cycles. The treatment was carried out under vision
and laparoscopic ultrasound guidance.
Results: The operation times were 170 and 300 minutes, with minimal
blood loss and no complications. The hospital stay was 2 and 5 days. The
estimated GFR did not change. There is no radiological evidence of
recurrence in one patient at 20 months, the second patient approaches 6
months follow-up.
Conclusion: Cryotherapy is an alternative safe treatment option for
multiple small renal tumours in high risk candidates.PATIENT PERCEPTIONS OF URODYNAMIC INVESTIGATION
Elizabeth Bright, Brian A. Parsons, Lucy Swithinbank. Department of
Urodynamics, Southmead Hospital, Bristol
Introduction: Patients are considerably anxious before urodynamic
investigations (UDSI). Anecdotally, patients’ perceptions of UDSI improve
following the test. The aim of this study is to investigate patients’
perceptions before and after UDSI.
Method: 80 consecutive patients recorded their pre-test anxiety level on
a 10cm visual analogue scale (VAS) ranging from “not at all anxious” to
“extremely anxious”. Immediately after UDSI, all patients were asked to
record on the VAS the level of anxiety they felt towards UDSI being
repeated. A two-tailed t-test was performed to identify any difference
between pre and post test VAS.
Results: 31 males and 49 females (25-82 years, mean 58.53 years) were
included in the study. All had the procedure explained to them before
completing the VAS. VAS reduced post-test in 58, increased in 8 and
remained unchanged in 14 patients. The mean pre-test score (3.93) was
signiﬁcantly greater than the mean post-test score (1.69), (mean difference
¼ 2.25, SD ¼ 2.47); t stat ¼ 8.14, p<0.001, suggesting that patients’
perceptions regarding further UDSI testing is improved.
Conclusion: 72.5% of patients were less anxious about having a repeat
UDSI. This information can be used in future to reassure patients.A SINGLE–INSTITUTION EXPERIENCE IN USE OF BACILLE CALMETTE-
GUERIN (BCG) IN SUPERFICIAL BLADDER CANCER
Naveed Altaf 1, Parveen Menezes 2, Rakesh Heer 1,2. 1 Sunderland Royal
Hospital, Sunderland; 2 Freeman Hospital, Newcastle upon Tyne
Introduction: Intravesicle BCG decreases the risk of progression in
bladder cancer. The aim of the study was to assess if maintenance BCG is
reliably achieved beyond 12 months.
Methods: Between April 2005- August 2008, 54 patients were started on
BCG maintenance therapy. We analyzed patient case notes, and assessed
the duration of BCG treatment as our primary measure, and reasons for
failure to complete maintenance and clinical outcome as secondary
measure.Results: Of the 54 patients identiﬁed, 16 (26.6%) had low risk, 10 (18.5%)
intermediate risk and 28 (51.9%) had high-risk superﬁcial bladder cancer.
Only 12 (22.2%) completed the full course of maintenance treatments at 6
monthly intervals. 28 (51.9%) completed at least 12months of maintenance
therapy. Of 14 (25.9%)patients who failed to complete 12 months of BCG
maintenance therapy, 7(50%)had disease progression, 5(35.7%) had BCG
related side effects and 2(14.3%)died. Of 5 patients who stopped treatment
due to side effects, 4 of then had progression of disease. Out of the 11
patients who had disease progression, 4(36.4%) underwent cystectomy.
Conclusion: Initial BCG therapy and cystectomy could the answer for high
drop off rates and toxicity with use of maintenance BCG in High-grade
superﬁcial bladder cancers.ROUTINE EARLY POST-OPERATIVE DUPLEX SCANNING IS UNNECESSARY
FOLLOWING CAROTID ENDARTERECTOMY
D.C. Smith, C.J.T. Urquhart, P. Jumar, T.O. Oshodi. Royal Oldham Hospital
(Pennine Acute Hospitals NHS Trust)
Introduction: The primary aim of the study was to determine whether
routine early duplex scanning following carotid endarterectomy (CEA) is
beneﬁcial in identifying recurrent or residual disease and whether it has
any role in preventing further neurological events.
Methods: A retrospective review of patient case-notes was performed on
all patients undergoing CEA between January 2001 and March 2008.
Patients had post-operative duplex scans within 3 months of surgery.
Results: There were 184 CEA operations performed during the assessed
period. The mean patient age was 68 years (range 49-88 years). Male to
female ratio was 127:57. Of these 127 were performed under general
anaesthesia and 57 under local anaesthesia. Three patients (1.6%) died in
the early post-operative period. Abnormalities were detected in 9 (10.3%)
cases. Two had occlusions, 2 ulceration, 1 thrombus, 8 with residual
stenosis of 50-60%, and 6 with a residual stenosis of 60-70%. None of the
scanned patients had clinical symptoms related to the carotid territory on
which had been operated.
Discussion: These results show that early post-CEA duplex scanning is of
limited clinical value. However, this practice is reassuring for the patient
and provides good documentary evidence of quality control and the
technical abilities of surgical trainees.BENCHMARK ASSESSMENT VERSUS LOCAL AUDIT FOR THE
MANAGEMENT OF PATIENTS WITH POTENTIALLY CURATIVE
OESOPHAGO-GASTRIC CANCER
C.N. Parnaby, R. Coggins, A. Tamijmarane. Raigmore Hospital, Inverness
Aims: North of Scotland Cancer Network (NOSCAN) have used a bench-
mark assessment (BA) to report current practice and service quality for
patients with oesophago-gastric (OG) cancer in the North of Scotland. The
assessment was based on SIGN 87 (management of OG cancer, 2006). Our
aimwas to compare results of BA against a local audit for the management
of patients with potentially curative OG cancer.
Methods: A retrospective audit was performed of patients referred with
potentially curative OG cancer (March 2005 –March 2009). Data extracted
included the 69 recommendations detailed in the NOSCAN assessment.
The audit data was compared to the BA response.
Results: 75 consecutive patients underwent potentially curative resection
(oesophageal [n ¼ 25], junctional [n ¼ 26] and gastric [n ¼ 24]). The BA
